Foghorn Hosted Virtual Investor Event Information Title: Pipeline Updates for Selective ARID1B, Selective CBP and Selective EP300 Degrader Programs Date/Time: Thursday, October 30, 2025 at 12 p.m. EDT ...

Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal ...

Foghorn Therapeutics shares are trading higher by 44.8% Thursday. The company announced that Eli Lilly has chosen FHD-909 for clinical development. 3 Summer "Power Patterns" Are About to Trigger (One ...

Eli Lilly & Co. said Monday it has entered a strategic collaboration with Foghorn Therapeutics Inc. for novel oncology targets using Foghorn's proprietary gene traffic control platform, a move that ...

The foghorn at the South Breakwater Light station, on the ship canal, was quite a presence in Duluth when I was a very little girl. My earliest memory of it, however, was not until just before I ...

SUNNYVALE, Calif.--(BUSINESS WIRE)--FogHorn, a leading developer of edge computing AI software for industrial and commercial Internet of Things (IoT) solutions, today announced plans to collaborate ...

SUNNYVALE, Calif.--(BUSINESS WIRE)--FogHorn, a leading developer of Edge AI software for industrial and commercial Internet of Things (IoT) solutions, today celebrates accolades for technology ...

Foghorn Therapeutics (FHTX) announced key development updates for its Selective ARID1B degrader program which will be presented as part of a ...